Generex Biotechnology Corp (GNBT):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Generex Biotechnology Corp (GNBT) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C12171
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:38
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Generex Biotechnology Corp (Generex) carries out the research, development and commercialization of drug delivery systems and technologies. It developed a proprietary platform technology to deliver drugs into the human body through the oral cavity. The company’s proprietary liquid formulations allow drugs typically administered by injection to be absorbed into the body by the lining of the inner mouth using its proprietary RapidMist device. Generex through its subsidiary, Antigen Express, has expanded its focus to include immunomedicines incorporating proprietary vaccine formulations for the treatment of infectious, malignant, allergic, and autoimmune diseases. Generex is headquartered in Miramar, Florida, the US.

Generex Biotechnology Corp (GNBT) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Generex Biotechnology Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Generex Biotechnology Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Generex Biotechnology Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Generex Biotechnology Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Generex Biotechnology Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Generex Biotechnology Corp, Medical Equipment, Deal Details 10
Partnerships 10
Generex Biotech Enters into Licensing Agreement with CannScience Innovations 10
Generex Biotech to Enter into Co-Development Agreement with NHTherapeutics 11
Equity Offering 12
Generex Biotec Announces Private Placement Of Units For USD2 Million 12
Generex Biotechnology Raises USD0.8 Million in Private Placement of Series E 9% Convertible Preferred Stock and Warrants 14
Generex Biotechnology Announces Private Placement Of Units For US$1.2 Million 15
Generex Biotech Completes Private Placement Of Units For US$0.8 Million 16
Generex Biotechnology Completes Private Placement Of Units For US$0.75 Million 17
Generex Biotech Completes Private Placement Of Units For US$2 Million 18
Acquisition 20
Generex Biotech to Acquire Remaining 49% Stake in Hema Diagnostic Systems 20
Generex Biotech to Acquire 51% Stake in Regentys 21
Generex Biotech to Acquire 51% Stake in Olaregen Therapeutix 22
Generex Biotech Acquires 51% Interest in Hema Diagnostic Systems for USD15 Million 23
Generex Biotechnology to Acquire 51% Stake in MediTemp for USD5 Million 24
Generex Biotech to Acquire 51% Stake in Alfa Rhythm for USD5 Million 25
Generex Biotechnology Corp – Key Competitors 26
Generex Biotechnology Corp – Key Employees 27
Generex Biotechnology Corp – Locations And Subsidiaries 28
Head Office 28
Other Locations & Subsidiaries 28
Recent Developments 29
Corporate Communications 29
Nov 15, 2018: Generex announces appointment of executive management team 29
Oct 12, 2018: Generex announces Anthony S. Crisci, Esq., CPA as general manager, chief compliance officer and corporate counsel of its new, wholly-owned subsidiary, NuGenerex distribution solutions 31
Jun 25, 2018: Generex Names Terry Thompson As Chief Operating Officer 32
Jan 25, 2017: Yutaka Niihara, MD, MPH, CEO of Emmaus Appointed Executive Chairman of Generex Biotechnology 33
Product News 34
Jul 02, 2018: Generex Biotechnology Announces the Filing of a Patent for its New Diagnostic Point-of-Care Platform, the Express II 34
Other Significant Developments 35
Jan 04, 2018: Generex CEO Provides 2017 Year-End Summary to Stakeholders 35
Appendix 38
Methodology 38
About GlobalData 38
Contact Us 38
Disclaimer 38

List of Tables
Generex Biotechnology Corp, Medical Equipment, Key Facts, 2017 2
Generex Biotechnology Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Generex Biotechnology Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Generex Biotechnology Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Generex Biotechnology Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Generex Biotechnology Corp, Deals By Market, 2012 to YTD 2018 8
Generex Biotechnology Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Generex Biotech Enters into Licensing Agreement with CannScience Innovations 10
Generex Biotech to Enter into Co-Development Agreement with NHTherapeutics 11
Generex Biotec Announces Private Placement Of Units For USD2 Million 12
Generex Biotechnology Raises USD0.8 Million in Private Placement of Series E 9% Convertible Preferred Stock and Warrants 14
Generex Biotechnology Announces Private Placement Of Units For US$1.2 Million 15
Generex Biotech Completes Private Placement Of Units For US$0.8 Million 16
Generex Biotechnology Completes Private Placement Of Units For US$0.75 Million 17
Generex Biotech Completes Private Placement Of Units For US$2 Million 18
Generex Biotech to Acquire Remaining 49% Stake in Hema Diagnostic Systems 20
Generex Biotech to Acquire 51% Stake in Regentys 21
Generex Biotech to Acquire 51% Stake in Olaregen Therapeutix 22
Generex Biotech Acquires 51% Interest in Hema Diagnostic Systems for USD15 Million 23
Generex Biotechnology to Acquire 51% Stake in MediTemp for USD5 Million 24
Generex Biotech to Acquire 51% Stake in Alfa Rhythm for USD5 Million 25
Generex Biotechnology Corp, Key Competitors 26
Generex Biotechnology Corp, Key Employees 27
Generex Biotechnology Corp, Subsidiaries 28

List of Figures
Generex Biotechnology Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Generex Biotechnology Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Generex Biotechnology Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Generex Biotechnology Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Generex Biotechnology Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Generex Biotechnology Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Generex Biotechnology Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Generex Biotechnology Corp, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Generex Biotechnology Corp (GNBT):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Putzmeister Holding GmbH:企業の戦略・SWOT・財務情報
    Putzmeister Holding GmbH - Strategy, SWOT and Corporate Finance Report Summary Putzmeister Holding GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Harvard Medical School-製薬・医療分野:企業M&A・提携分析
    Summary Harvard Medical School (HMS), a subsidiary of Harvard University is a medical institute that offers education, research and clinical care services. The institute offers various degree programs such as bachelor's program, master's program, PhD program, and continuing education. It offers prog …
  • Hoerbiger Holding AG:企業の戦略的SWOT分析
    Hoerbiger Holding AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Merus Labs International Inc (MSL):企業の財務・戦略的SWOT分析
    Summary Merus Labs International Inc (Merus Labs International), formerly Merus Labs Inc, a subsidiary of Norgine BV, is a pharmaceutical company that provides medicinal products. The company offers products in the therapeutic areas of cardiovascular, oncology support, women's health, urology, and i …
  • Pancontinental Oil & Gas NL (PCL):企業の財務・戦略的SWOT分析
    Summary Pancontinental Oil & Gas NL (Pancontinental) is an oil and gas exploration and production company. The company carries out acquisition, exploration and development of conventional oil and gas properties. The company offers projects such as Namibia Walvis Basin EL 0037, Kenya Lamu Basin L6, T …
  • Intercept Energy Services Inc (IES):石油・ガス:M&Aディール及び事業提携情報
    Summary Intercept Energy Services Inc (Intercept Energy), formerly Global Green Matrix Corp is an oilfield service firm that offers water heating services. The firm provides services such as oilfield services, energy extraction and related services, frac water heating, oil sands processing, and oilf …
  • Suelopetrol CA SACA:企業の戦略的SWOT分析
    Suelopetrol CA SACA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Mitsubishi Heavy Industries, Ltd.:企業の戦略・SWOT・財務情報
    Mitsubishi Heavy Industries, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Mitsubishi Heavy Industries, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Baylor College of Medicine:企業のM&A・事業提携・投資動向
    Baylor College of Medicine - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Baylor College of Medicine Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • Nova Kreditna banka Maribor d. d.:企業の戦略・SWOT・財務分析
    Nova Kreditna banka Maribor d. d. - Strategy, SWOT and Corporate Finance Report Summary Nova Kreditna banka Maribor d. d. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Parmalat S.p.A.:企業の戦略・SWOT・財務情報
    Parmalat S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Parmalat S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Italcementi S.p.A:企業の戦略的SWOT分析
    Italcementi S.p.A - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Reliance Anil Dhirubhai Ambani Group:企業の戦略的SWOT分析
    Reliance Anil Dhirubhai Ambani Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • Saertex GmbH & Co KG:企業の戦略的SWOT分析
    Saertex GmbH & Co KG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Nutritional Resources Inc:企業の戦略・SWOT・財務情報
    Nutritional Resources Inc - Strategy, SWOT and Corporate Finance Report Summary Nutritional Resources Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Xped Ltd (XPE):企業の財務・戦略的SWOT分析
    Xped Ltd (XPE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Abreos Biosciences Inc:医療機器:M&Aディール及び事業提携情報
    Summary Abreos Biosciences Inc (Abreos) is a biotechnology company with focus on the development of laboratory-based and point-of-care (POC) assays and reagents for the precision dose monitoring of biologic drugs. Its Monator, is a drug-monitoring test that provides physicians with vital information …
  • Saras SpA (SRS):電力:M&Aディール及び事業提携情報
    Summary Saras SpA (Saras) is crude oil refiner and operates refining, marketing, power generation and wind power businesses. The company’s major refinery is Sarroch refinery, on the Southwestern coast of Sardinia. Saras is also active in the production and sale of electricity, and offers industrial …
  • Hycrete Inc:企業の戦略的SWOT分析
    Hycrete Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • EKF Diagnostics Holdings Plc (EKF):企業の財務・戦略的SWOT分析
    EKF Diagnostics Holdings Plc (EKF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆